Fungal infections associated with CD19-targeted chimeric antigen receptor T cell therapy Review

  


Authors: Gaulin, C.; Harris, Z.; Kodama, R.; Shah, M.; Blair, J.; Wang, Y.; Lin, Y.; Muñoz, J.
Review Title: Fungal infections associated with CD19-targeted chimeric antigen receptor T cell therapy
Abstract: Purpose of Review: This review focuses on the epidemiology of fungal infections after CD19-targeted chimeric antigen receptor (CAR) T cell therapy and associated risk factors for their development and describes infectious disease screenings and antifungal prophylactic strategies. Recent Findings: Epidemiologic studies characterizing fungal infections in patients with hematologic malignancies treated with CD19-targeted CAR T cell therapy are scarce. Fungal infections occur in approximately 2–13% of CAR T cell recipients, both early and late after infusion. Candida, Aspergillus, and Pneumocystis are the most common culprit pathogens. Invasive fungal infections seldom contribute to mortality. While various risk factors for the development of fungal infections have been proposed, all relate to dysregulation in innate and adaptive immunity. Exposure to areas where endemic fungi are known to be present in the environment may also be a risk factor. Infectious disease screenings and prophylactic strategies vary broadly across institutions. Summary: Although data are limited, fungal infections occur in a small proportion of patients after CD19-targeted CAR T cell therapy. Additional studies are needed to better describe fungal infection epidemiology, individualize infectious disease screenings, and inform antifungal prophylaxis in this population. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Keywords: adoptive immunotherapy; non-hodgkin lymphoma; antifungal prophylaxis; car t cell therapy; invasive fungal infections; endemic mycoses
Journal Title: Current Fungal Infection Reports
Volume: 17
Issue: 2
ISSN: 1936-3761
Publisher: Springer Healthcare  
Date Published: 2023-06-01
Start Page: 87
End Page: 97
Language: English
DOI: 10.1007/s12281-023-00460-6
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150252770&doi=10.1007%2fs12281-023-00460-6&partnerID=40&md5=3650e57929a6cc0cf72459138884c9d0
Notes: Review -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Monika Shah
    22 Shah
  2. Rich Kodama
    7 Kodama
Related MSK Work